Envisage report cover

Pharmaceutical Excipients Market - By Product (Organic Chemicals, Inorganic Chemicals, Other Devices) By Functionality (Fillers and Diluents, Suspending and Viscosity Agents, Coating Agents, Binders, Flavouring Agents and Sweeteners, Dis-integrants, Colorants, Lubricants and Glidants, Preservatives, Emulsifying Agents, Other Functionalities) By Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Formulations) By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 188

Status: Published

Report Code: EMR100745

The pharmaceutical excipients market is projected to reach USD 11.14 billion by 2027 from USD 7.36 billion in 2020, at a CAGR of 6.1 %. Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients.

The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing industry also present significant growth opportunities for market players in the pharmaceutical excipients market. The world has been witnessing rising demand for medicines, led by an increase in the number of chronic diseases, greater awareness towards physical well-being, and rising incidence of lifestyle diseases such as diabetes and obesity-related disorders. This has been fueling demand for and production of drugs and thus excipients. Excipients are believed to aid active pharmaceutical ingredients achieve better functionalities such as longer shelf-life, and also render competitive advantage in formulation.

Demand for oral solid drug formulations has been witnessing a steady increase over the past few years owing to ease of consumption by patient classes, including children. Oral dosage forms generally require more amount of excipients than other forms during the drug manufacturing process and is being promoted due to adoption of increased patient-centricity approaches by drug manufacturers. For example, over 50% of patients find it difficult to swallow conventional hard solid tablets. This has prompted drug companies to devise more innovative solid oral product forms such as orally disintegrating granules (ODGs), effervescent tablets, lozenges, instant drinks, and chewable tablets. This is expected to create substantial demand for excipients in the near future.
Lack of separate guidelines for manufacturing and approval of excipients is deterring R&D initiatives related to novel excipients. Under the present regulatory scenario, if a new drug approval (NDA) fails, the excipients also fails even if it is not due to anything related to the excipients. Furthermore, clinical trial data from that failed excipients is not usable. This leads to major financial loss on the part of both the drug and the excipients manufacturer. The cost and time frame to develop novel excipients under proper regulatory compliances are both uneconomical for manufacturers, thus limiting the outlook for getting a novel excipients approved.

DuPont de Nemours, Inc. (US) and RoquetteFeres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation(US), and Croda International (UK). Other players in this market are Innophos Holdings (US), Kerry Group plc (Ireland), WACKER Chemie AG (Germany), Colorcon, Inc. (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).

Roquette (France) is a major player in the market. The company has an extensive product line and has a dominant position, especially in the carbohydrate excipients segment. In this regard, In January 2018, Roquette launched a new carbohydrate excipients product from its facility in India. The company also launched three new excipients brands in March 2017. Roquette (France) has a commercial presence in over 100 countries across North America, Europe, and Asia. It has 30 global establishments, including 20 production sites located across Germany, China, Korea, Spain, the US, France, India, Italy, Romania, and the UK. For its future growth, Roquette intends to further strengthen its existing relationships with key customers by organizing customer meetings, field visits, and training sessions on proactive quality management regularly in order to understand company functionalities and product portfolios better.

Analyst Commentary

The growth of the global market of pharmaceutical excipients is driven by the factors such as growing demand of functional excipients, increasing demand of generics, and emergence of new excipients in the market.

On the basis of product, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in the majority of pharmaceutical formulations available in the pharmaceutical market.

On the basis of functionality, the fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market in 2018. The large share of this segment is attributed to the increased use of fillers and diluents in the development and production of solid oral drugs and the advantages they offer to manufacturers and patients.

Based on formulation, the market for topical formulations is expected to witness the highest growth during the forecast period. Growth in this segment is majorly due to better assimilation of topical excipients with liquid APIs and increased patient compliance due to sensorial effects.

Segmentation

The pharmaceutical excipients market is segmented based on product, functionality, formulation and region. Based on product , the industry is segmented into organic and inorganic chemicals and other devices .. Based on functionality, the world market is classified into fillers and diluents, binders, coatings, flavouring agents, disintegrants, colorants, and others. On the basis of formulation the market is segmented into Oral Formulations, topical Formulations, Parenteral Formulations, and Other Formulations. The industry has been analyzed on the basis of regions, namely North America, Europe, Asia-Pacific, and LAMEA.

Regional Analysis

The North America pharmaceutical market has a high demand for new drug formulations, which results in high demand for excipients in the region. Europe holds the second position in the overall pharmaceutical excipients market. Asia Pacific pharmaceutical excipients market is projected to expand at a substantial growth rate contributing the significant share in the global pharmaceutical excipients market, as India and China has become the largest supplier to the manufacturers outsourcing the pharmaceutical excipients due to its cheap labor and low cost of manufacturing.

The Middle East and Africa contribute to the market of global pharmaceutical excipients infinitesimally, as it is still experiencing a growing phase. Recent studies show that major pharmaceutical companies are expanding their segment in developing regions which are anticipated to enhance the market growth in subsequent years.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Pharmaceutical Excipients Market
Chapter 5. Global Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
5.1. Global Pharmaceutical Excipients Market Share, By Product, 2015 - 2027 (USD Million)
5.1.1. Organic & Inorganic Chemicals
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Other devices
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
6.1. Global Pharmaceutical Excipients Market Share, By Functionality, 2015 - 2027 (USD Million)
6.1.1. Fillers & Diluents
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Binders
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Coatings
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Flavoring agents
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. Disintegrants
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.6. Colorants
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Pharmaceutical Excipients Market Overview, By Formulation, 2015 - 2027(USD Million)
7.1. Global Pharmaceutical Excipients Market Share, By Formulation, 2015 - 2027 (USD Million)
7.1.1. Oral Formulations
7.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Topical formulations
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Parental formulations
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Pharmaceutical Excipients Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Pharmaceutical Excipients Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.2. North America Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.3. North America Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.4. North America Pharmaceutical Excipients Market Overview, By Formulation, 2015 - 2027 (USD Million)
9.1.5. North America Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
10.1.3. Europe Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
10.1.4. Europe Pharmaceutical Excipients Market Overview, By Formulation,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.2.3. France Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.3.3. UK Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Pharmaceutical Excipients Market Overview, By Functionality 2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Pharmaceutical Excipients Market Overview, By Formulation,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.1.3. India Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.2.3. China Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Pharmaceutical Excipients Market Overview, By Formulation,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Pharmaceutical Excipients Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Pharmaceutical Excipients Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Size and projections, 2015 - 2027 (USD Million)
13.1.2. South America Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
13.1.3. South America Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.4. South America Pharmaceutical Excipients Market Overview, By Formulation,2015 - 2027 (USD Million)
13.1.5. South America Pharmaceutical Excipients Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2027 (USD Million)
13.1.6.2. Brazil Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
13.1.6.3. Brazil Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2027 (USD Million)
13.1.7.2. Argentina Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
13.1.7.3. Argentina Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2027
13.1.8.2. Rest of South America Pharmaceutical Excipients Market Overview, By Product, 2015 - 2027 (USD Million)
13.1.8.3. Rest of South America Pharmaceutical Excipients Market Overview, By Functionality, 2015 - 2027 (USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. DuPont de Nemours
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Roquette
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Ashland global holdings
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. BASF SE
15.5. Archer daniels midland company
15.6. Lubrizol corporation
15.7. Croda International
15.8. WACKER Chemie AG
15.9. Colorcon Inc
15.10. Others
Chapter 16. Pharmaceutical Excipients Market Cost Analysis
16.1. Pharmaceutical Excipients Market Key Size Analysis
16.1.1. Key Size
16.1.2. Price Trend of Key Size
16.1.3. Key Suppliers of Size
16.1.4. Market Concentration Rate of Size
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Pharmaceutical Excipients Market Chain Analysis
17.2. Upstream Size Sourcing
17.3. Pharmaceutical Excipients Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Pharmaceutical Excipients Market share, By Product, 2020 & 2027 (%)
10. Global Pharmaceutical Excipients Market share, by Organic & Inorganic Chemicals, By Product, 2015 - 2027 (USD Million)
11. Global Pharmaceutical Excipients Market share, by Other devices, By Product, 2015 - 2027 (USD Million)
12. Global Pharmaceutical Excipients Market share, By Functionality, 2020 & 2027 (%)
13. Global Pharmaceutical Excipients Market share, by Fillers & Diluents, By Functionality, 2015 - 2027 (USD Million)
14. Global Pharmaceutical Excipients Market share, by Binders, By Functionality 2015 - 2027 (USD Million)
15. Global Pharmaceutical Excipients Market share, by Coatings, By Functionality 2015 - 2027 (USD Million)
16. Global Pharmaceutical Excipients Market share, by Flavoring agents, By Functionality 2015 - 2027 (USD Million)
17. Global Pharmaceutical Excipients Market share, by Disintegrants, By Functionality 2015 - 2027 (USD Million)
18. Global Pharmaceutical Excipients Market share, by Colorants, By Functionality 2015 - 2027 (USD Million)
19. Global Pharmaceutical Excipients Market share, By Formulation, 2020 & 2027 (%)
20. Global Pharmaceutical Excipients Market share, by Oral Formulations, By Formulation, 2015 - 2027 (USD Million)
21. Global Pharmaceutical Excipients Market share, by Topical formulations, By Formulation 2015 - 2027 (USD Million)
22. Global Pharmaceutical Excipients Market share, by Parental formulations, By Formulation 2015 - 2027 (USD Million)
23. Global Pharmaceutical Excipients Market share, by Others, By Formulation 2015 - 2027 (USD Million)
24. Global Pharmaceutical Excipients Market share, by region, 2020 & 2027 (%)
25. Global Pharmaceutical Excipients Market share, by region, 2015 - 2027(USD Million)
26. North America Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
27. North America Pharmaceutical Excipients Market share, by Countries, 2020 & 2027 (%)
28. U.S. Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
29. Canada Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
30. Mexico Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
31. Europe Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
32. Europe Pharmaceutical Excipients Market share, by Countries, 2020 & 2027 (%)
33. Spain Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
34. UK Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
35. Italy Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
36. Germany Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
37. France Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
38. Rest of Europe Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
39. Asia-Pacific Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
40. Asia-Pacific Pharmaceutical Excipients Market share, by Countries, 2020 & 2027 (%)
41. China Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
42. India Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
43. Australia Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
44. Japan Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
45. Rest of Asia-Pacific Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
46. Middle East & Africa Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
47. Middle East & Africa Pharmaceutical Excipients Market share, by Countries, 2020 & 2027 (%)
48. GCC Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
49. South Africa Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
50. Rest Of Middle East & Africa Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
51. South America Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
52. Brazil Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
53. Mexico Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
54. Argentina Pharmaceutical Excipients Market, 2015 - 2027(USD Million)
55. Rest Of South America Pharmaceutical Excipients Market, 2015 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Pharmaceutical Excipients Market, 2015-2027 (USD Million)
4. Pharmaceutical Excipients requirement, by country, 2015-2027, (USD Million)
5. North America Pharmaceutical Excipients Market, By Product, 2015-2027 (USD Million)
6. North America Pharmaceutical Excipients Market, By Functionality, 2015-2027 (USD Million)
7. North America Pharmaceutical Excipients Market, By Formulation, 2015-2027 (USD Million)
8. Europe Pharmaceutical Excipients Market, By Product, 2015-2027 (USD Million)
9. Europe Pharmaceutical Excipients Market, By Functionality, 2015-2027 (USD Million)
10. Europe Pharmaceutical Excipients Market, By Formulation, 2015-2027 (USD Million)
11. Asia Pacific Pharmaceutical Excipients Market, By Product, 2015-2027 (USD Million)
12. Asia Pacific Pharmaceutical Excipients Market, By Functionality, 2015-2027 (USD Million)
13. Asia Pacific Pharmaceutical Excipients Market, By Formulation, 2015-2027 (USD Million)
14. Middle East & Africa Pharmaceutical Excipients Market, By Product, 2015-2027 (USD Million)
15. Middle East & Africa Pharmaceutical Excipients Market, By Functionality, 2015-2027 (USD Million)
16. Middle East & Africa Pharmaceutical Excipients Market, By Formulation, 2015-2027 (USD Million)
17. South America Pharmaceutical Excipients Market, By Product, 2015-2027 (USD Million)
18. South America Pharmaceutical Excipients Market, By Functionality, 2015-2027 (USD Million)
19. South America Pharmaceutical Excipients Market, By Formulation, 2015-2027 (USD Million)
20. Global Pharmaceutical Excipients Market, Company Market Share, 2020 - 2027 (%)
21. DuPont de Nemours: Source Benchmarking
22. DuPont de Nemours: Financial Performance
23. Roquette: Source Benchmarking
24. Roquette: Financial Performance
25. Ashland global holdings: Source Benchmarking
26. Ashland global holdings: Financial Performance
27. BASF SE: Source Benchmarking
28. BASF SE: Financial Performance
29. Archer daniels midland company: Source Benchmarking
30. Archer daniels midland company: Financial Performance
31. Lubrizol corporation: Source Benchmarking
32. Lubrizol corporation: Financial Performance
33. Croda International: Source Benchmarking
34. Croda International: Financial Performance
35. LAPI GELATINE: Source Benchmarking
36. LAPI GELATINE: Financial Performance
37. WACKER Chemie AG: Source Benchmarking
38. WACKER Chemie AG: Financial Performance
39. Colorcon Inc: Source Benchmarking
40. Colorcon Inc: Financial Performance

The Leading Key Players in Pharmaceutical Excipients Market

DuPont de Nemours Inc. (US) and RoquetteFeres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings Inc. (US)
BASF SE (Germany)
Evonik Industries AG (Germany)
Associated British Foods plc (UK)
Archer Daniels Midland Company (US)
Lubrizol Corporation(US)
Croda International (UK). Other players in this market are Innophos Holdings (US)
Kerry Group plc (Ireland)
WACKER Chemie AG (Germany)
Colorcon Inc. (US)
DFE Pharma (Germany)
JRS Pharma (Germany)
Air Liquide (France).